• 제목/요약/키워드: Nodal Metastasis

검색결과 156건 처리시간 0.028초

위암 환자에서 수술 전 복막전이 예측을 위한 혈청 종양 표지자의 유용성: CA 19-9와 CEA (The Usefulness of Serum Tumor Markers as a Predictor of Peritoneal Metastasis in Patients with Gastric Carcinoma: CA 19-9 and CEA)

  • 정오;주재균;박영규;유성엽;정미란;김호군;김동의;김영진
    • Journal of Gastric Cancer
    • /
    • 제8권3호
    • /
    • pp.129-135
    • /
    • 2008
  • 목적: 다른 소화기계 악성종양에 비하여 위암에서 종양표지자의 역할은 매우 제한적이다. 여러 연구들에서 종양표지자는 예후 및 재발과 밀접한 연관이 있음이 보고되었으나, 종양표지자를 이용한 수술 전 원격전이 예측의 유용성에 관한 보고는 매우 드물다. 대상 및 방법: 2004년부터 2006년까지 본원에서 위암으로 수술을 시행 받은 환자 중 종양 표지자의 비특이적 증가를 초래하는 요인을 가진 환자를 제외한 788명의 환자를 대상으로 수술 전 CEA, CA 19-9와 임상병리학적 특성간에 상관관계를 분석하였다. 결과: CEA 양성여부는 연령, 성별과 같은 종양과 무관한 비특이적 인자에 의해서도 영향을 받으며, 림프절 전이여부와 독립적인 상관관계가 있었으나 종양의 침윤도와는 상관관계가 없었다. 원격전이의 예측에서 CEA는 복막전이나 혈행성 전이와 유의한 상관관계가 없었다. 이에 비해 CA 19-9는 종양의 침윤도 림프절 전이와 각각 독립적인 상관관계를 보였으며, 원격전이 중 복막 전이여부와 유의한 상관관계를 보였다. 특히, 증가 정도에 따라 CA 19-9가 5배 이상 증가 시에 복막전이에 대한 위험도가 유의하게 증가함을 보였다. 결론: CA 19-9는 측정이 간편하고 용이할 뿐만 아니라, 수술 전 비치유인자인 복막전이를 예측하는데 도움을 줌으로써, 이에 따른 환자의 추가적인 검사를 통하여 적절한 치료 방침을 세우는데 임상적으로 유용한 도구라고 판단된다.

  • PDF

유두상 갑상선암에서 nm23, Bcl2, Bax 발현도의 임상적 의의 (Significance of nm23, Bcl2 and Bax Expression in Papillary Thyroid Carcinoma)

  • 정웅윤;이해경;백소야;박정수
    • 대한두경부종양학회지
    • /
    • 제16권2호
    • /
    • pp.161-166
    • /
    • 2000
  • Objective: The nm23 gene has been identified as a potential metastasis suppressor gene in various human neoplasms. Both Bcl-2, which promotes cell survival, and Bax, which promotes cell death, have been considered as major factors in controlling the apoptotic pathway. This study was carried out to determine whether these markers are useful in distinguishing potential intrinsic differences in tumor virulence of papillary thyroid cancers. Material and Method: The expressions of nm23, Bcl-2 and Bax have been evaluated using immunohistochemical techniques in 100 pure papillary thyroid cancers and 20 metastatic lymphnodes. The intensity of immnunoreactivity was graded on arbitrary four point scale(grade 0 or 1 : negative reactivity, grade 2 or 3 positive reactivity). The immunoreactivities were analyzed in relation to TNM atage, AMES score, local recurrence and distant metastasis, and that of metastatic LNs was compared with the tumors. Results: The expression of Bcl-2 and bax did not show any statistical differences by TNM stage, AMES score, recurrence, distant metastasis and also between the tumor and metastatic LN. However, the nm23 showed higher expression of Ki67 in distant metastasis than in control group and in metastatic LNs than in the tumors(p<0.05). Conclusion: Although the expression of Bcl-2 and Bax protein showed no correlation with clinical parameters representing tumor virulence, the nm23 expression could be an useful prognostic factor, especially in predicting nodal or distant metastasis in papillary thyroid cancer.

  • PDF

Limited Clinical Significance of Splenectomy and Splenic Hilar Lymph Node Dissection for Type 4 Gastric Cancer

  • Kunitomo, Aina;Misawa, Kazunari;Ito, Yuichi;Ito, Seiji;Higaki, Eiji;Natsume, Seiji;Kinoshita, Takashi;Abe, Tetsuya;Komori, Koji;Shimizu, Yasuhiro
    • Journal of Gastric Cancer
    • /
    • 제21권4호
    • /
    • pp.392-402
    • /
    • 2021
  • Purpose: Type 4 gastric cancer (GC) has a very poor prognosis even after curative resection, and the survival benefit of splenectomy for splenic hilar lymph node (LN; #10) dissection in type 4 GC remains equivocal. This study aimed to clarify the clinical significance of splenectomy for #10 dissection in patients with type 4 GC. Materials and Methods: The data of a total of 56 patients with type 4 GC who underwent total gastrectomy with splenectomy were retrospectively analyzed. Postoperative morbidity, state of LN metastasis, survival outcomes, and therapeutic value index (TVI) of each LN station were evaluated. TVI was calculated by multiplying the incidence of LN metastasis at each nodal station and the 5-year overall survival (OS) of patients who had metastasis to each node. Results: Overall, the postoperative morbidity rate was 28.6%, and the incidence of #10 metastasis in the patients was 28.6%. The 5-year OS rate for all patients was 29.9%, and most patients developed peritoneal recurrence. Moreover, the 5-year OS rates with and without #10 metastasis were 6.7% and 39.1% (median survival time, 20.4 vs. 46.0 months; P=0.006). The TVI of #10 was as low as 1.92. Conclusions: The clinical significance of splenectomy in the dissection of #10 for type 4 GC is limited and splenectomy for splenic hilar dissection alone should be omitted.

진행성 위암에서 종양 연관성 대식세포, 비만세포, 가지세포의 침윤과 임상-병리학적 인자와의 연관성 (Correlation between Infiltrations of Tumor-associated Macrophages, Mast Cells, and Dendritic Cells with Clinicopathologic Factors in Advanced Gastric Cancer)

  • 이승범;지경천
    • Journal of Gastric Cancer
    • /
    • 제5권3호
    • /
    • pp.206-212
    • /
    • 2005
  • 목적: 신생혈관형성은 암의 증식, 침습, 전이에 있어 중요한 과정이며 위선암에서 대식세포, 비만세포는 혈관내피세포성장인자를 통한 신생혈관형성 작용을 보이고 가지세포는 혈관내피세포성장인자에 의해 기능이 억제된다. 이들 세포의 조직 침습이 조직병리 및 임상예후와 어떤 상관관계를 가지는지 알아보고자 한다. 대상 및 방법: 1999년 1월부터 2002년 12월까지 진행성 위암으로 위절제술을 받은 환자 중 79명을 대상으로 하여 파라핀 포매 조직을 이용하여 대식세포, 비만세포, 가지세포 및 미세혈관에 대한 면역조직화학 염색을 실시하고, 이들의 발현과 임상병기 및 생존율에 대한 분석을 실시하였다. 결과: 대식세포의 수는 분화도가 낮을수록, 조직침습이 깊을수록, 림프절전이가 많을수록 유의하게 감소하였으나(P<0.05), 미세혈관 밀도 및 생존기간의 차이는 보이지 않았다. 비만세포와 가지세포의 침윤정도는 조직병리 및 생존율과의 연관성을 보이지 않았다. 결론: 종양연관성 대식세포가 위암환자에 있어 예후인자로 가치를 가질 수 있을 것 인지와 대식세포의 침습부위에 따른 임상적 관련성에 대해 좀 더 세부적인 연구가 필요할 것으로 사료된다.

  • PDF

Lack of any Impact of Histopathology Type on Prognosis in Patients with Early-Stage Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix

  • Teke, Fatma;Yoney, Adnan;Teke, Memik;Inal, Ali;Urakci, Zuhat;Eren, Bekir;Zincircioglu, Seyit Burhanedtin;Buyukpolat, Muhammed Yakup;Ozer, Ali;Isikdogan, Abdurrahman;Unsal, Mustafa
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권6호
    • /
    • pp.2815-2819
    • /
    • 2014
  • Background: The aim of this study was to evaluate the prognosis of patients with stage IA-IIB cervical carcinoma and to investigate a possible correlation of histology with prognosis. Materials and Methods: Two hundred fifty one patients with adenocarcinoma and squamous cell carcinoma (SCC) histology for FIGO (International Federation of Gynecology and Obstetrics) stage IA-IIB uterine cervical carcinomas at the Radiation Oncology Clinic of GH Okmeydan Training and Research Hospital between January 1996 and December 2006 were selected, analyzed retrospectively and evaluated in terms of general characteristics and survival. Disease-free survival (DFS) and overall survival (OS) was calculated using the Kaplan-Meier method and differences were compared with the log-rank test. Multivariate analysis using a Cox-proportional hazards model was used to adjust for prognostic factors and to estimate hazard ratio (HR) with 95% confidence interval (CI). Results: There was no differences between the two tumour types in age, stage, pelvic nodal metastasis, parametrial invasion, surgical margin status, DSI, LVSI, maximal tumor diameter, grade, and treatment modalities. 5-year OS and DFS were 73% and 77%, versus 64% and 69%, for SCC and adenocarcinoma, respectively (p> 0.05). Multivariate analysis revealed independent prognostic factors including pelvic nodal metastasis and resection margin status for OS (p=0.008, p=0.002, respectively). Conclusions: Prognosis of FIGO stage IA-IIB cervical cancer patients was found to be the same for those with adenocarcinoma and SCC.

Clinicopathologic Features of Breast Carcinomas Classified by Biomarkers and Correlation with Microvessel Density and VEGF Expression: A Study from Thailand

  • Chuangsuwanich, Tuenjai;Pongpruttipan, Tawatchai;O-charoenrat, Pornchai;Komoltri, Chulaluk;Watcharahirun, Suwapee;Sa-nguanraksa, Doonyapat
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권3호
    • /
    • pp.1187-1192
    • /
    • 2014
  • Background: To correlate breast cancer subtypes with prognostic factors, microvessel density (MVD), vascular endothelial growth factor (VEGF) expression and clinical features. Materials and Methods: One hundred cases of primary breast carcinoma were classified using biomarkers on tissue microarray as: luminal A [estrogen receptor (ER)+, HER2-, $Ki-67{\leq}14%$], luminal B [ER+, HER2+ or ER+, HER2-, Ki-67>14%], HER2, triple negative basal-like (TNB) [any basal cytokeratins (CKs, 5, 14, 17) and/or endothelial growth factor receptor (EGFR) expression], and TN without such markers [TNN, null], and assessed for p53, vimentin, VEGF and CD31 immunoperoxidase. Results: Of the 100 cases (mean age, 51 years; mean tumor size, 3.2cm; 56% with nodal metastasis; 89 invasive ductal carcinomas, not otherwise specified, 4 invasive lobular carcinomas, 3 metaplastic carcinomas, and 4 other types) there were 39 luminal A, 18 luminal B, 18 HER2, 15 TNB and 10 TNN. The positivities of basal-like markers in the basal-like subtype were 78.3% for CK5, 40% for CK14, 20% for CK17, 46.7% for EGFR. There was no significant difference in age distribution, tumor size, degree of tubular formation, pleomorphism, lymphovascular invasion, nodal metastasis, MVD, VEGF expression and survival among subgroups. TNs demonstrated significantly higher tumor grade, mitotic count, Ki-67 index, p53 and vimentin and decreased overall survival compared with nonTN. Conclusions: The distribution of breast cancer subtypes in this study was similar to other Asian countries with a high prevalence of TN. The high grade character of TN was confirmed and CK5 expression was found to be common in our basal-like subtype. No significant elevation of MVD or VEGF expression was apparent.

Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman - a Single Center Study

  • Kumar, Shiyam;Burney, Ikram A;Zahid, Khawaja Farhan;Souza, Philomena Charlotte D;Belushi, Muna AL;Mufti, Taha Dawood;Meki, Waeil AL;Furrukh, Muhammad;Moundhri, Mansour S AL
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권12호
    • /
    • pp.4853-4858
    • /
    • 2015
  • Background: Colorectal cancer is the most common gastrointestinal cancer in Oman with an increasing incidence. We here report the presenting features, treatment outcomes and survival in a University hospital in Oman and compare our data with regional and international studies. Materials and Methods: Medical records of patients with colorectal cancer were reviewed retrospectively between June 2000 and December 2013 and were followed until June 2014. Results: A total of 162 patients were diagnosed with colorectal cancer. The majority were males (58.6%), with a median age of 56 years. Rectum was involved in 29.6% of patients, followed by ascending and sigmoid colon. The majority of patients had stage III (42.6%) and stage IV (32.7%) disease at presentation. K-Ras status was checked for 79 patients, and 41 (51.9%) featured the wild type. Median relapse free survival was 22 months. Median overall survival for all patients was 43 months. Observed 5 year overall survival (OS) for stages I, II and III was 100%, 60% and 60% respectively. On Log rank univariate analysis, age, BMI, diabetes, hypertension, metformin use, stage, clinical nodal status for rectal cancer, pathological T and nodal status, site of metastasis, surgical intervention, chemotherapy, radiotherapy, chemotherapy regimen, no of cycles of chemotherapy, response, RFS, site of recurrence and administration of $2^{nd}$ line chemotherapy were significant factors affecting OS. On Cox regression multivariate analysis none of the factors independently affected the OS. Conclusions: The majority of patients present with advanced disease and at young age. The survival rates are comparable to the published regional and international literature.

Locoregional Spread and Survival of Stage IIA1 versus Stage IIA2 Cervical Cancer

  • Hongladaromp, Waroonsiri;Tantipalakorn, Charuwan;Charoenkwan, Kittipat;Srisomboon, Jatupol
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권2호
    • /
    • pp.887-890
    • /
    • 2014
  • This study was undertaken to compare surgical outcomes and survival rates of patients with the 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIA1 versus IIA2 cervical cancer treated with radical hysterectomy and pelvic lymphadenectomy (RHPL). Patients with stage IIA cervical cancer undergoing primary RHPL between January 2003 and December 2012 at Chiang Mai University Hospital were retrospectively reviewed. The analysis included clinicopathologic variables, i.e. nodal metastasis, parametrial involvement, positive surgical margins, deep stromal invasion (DSI)), lymph-vascular space invasion (LVSI), adjuvant treatment, and 5-year survival. The chi square test, Kaplan-Meier method and log-rank test were used for statistical analysis. During the study period, 133 women with stage IIA cervical cancer, 101 (75.9 %) stage IIA1, and 32 (24.1 %) stage IIA2 underwent RHPL. The clinicopathologic variables of stage IIA1 compared with stage IIA2 were as follows: nodal metastasis (38.6% vs 40.6%, p=0.84), parametrial involvement (10.9% vs 15.6%, p=0.47), positive surgical margins (31.7% vs 31.3%, p=1.0), DSI (39.6% vs 53.1%, p=0.18), LVSI (52.5% vs 71.9%, p=0.05) and adjuvant radiation (72.3% vs 84.4%, p=0.33). With a median follow-up of 60 months, the 5-year disease-free survival (84.6% vs 88.7%, p=0.67) and the 5-year overall survival (83.4% vs 90.0%, P=0.49) did not significantly differ between stage IIA1 and stage IIA2 cervical cancer. In conclusion, patients with stage IIA1 and stage IIA2 cervical cancer have comparable rates of locoregional spread and survival. The need for receiving adjuvant radiation was very high in both substages. The revised 2009 FIGO system did not demonstrate significant survival differences in stage IIA cervical cancer treated with radical hysterectomy. Concurrent chemoradiation should be considered a more suitable treatment for patients with stage IIA cervical cancer.

비소세포 폐암에서 종양 혈관신생과 병기 및 예후와의 관련성 (Relationship Between Tumor Angiogenesis, Stage and Prognosis in Non-Small Cell Lung Cancer)

  • 리원연;김정주;신표진;조미연;용석중;신계철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제50권5호
    • /
    • pp.557-567
    • /
    • 2001
  • 연구배경 : 종양 신생혈관은 종양조직에 산소 및 영양물질을 제공하고 종양조직에서 발생한 산과 독성 대시물질을 제거하여 종양의 성장을 가능하게 하며, 종양세포의 전신전이의 경로를 제공하는 역할을 하므로 종양의 혈관신생은 종양의 성장과 전이의 과정에서 필수적이다. 피부 악성흑색종이나 유암에서는 종양 혈관선생의 정도와 림프절 전이, 전선전이 및 예후와의 관련성이 잘 알려져 있다. 이에 본 연구에서는 비소세포성 폐암에서 종양 혈관신생 정도와 병기, 림프절 전이, 전선전이 및 예후와의 관련성에 대하여 알아보고자 하였으며 아울러 조직학적 유형간에 종양 혈관선생 정도의 차이가 있는 지에 대하여 알아보고자 하였다. 방 법 : 1989년 3월 1일부터 1998년 6월 30일까지 연세대학교 원주의과대학 원주기독병원에서 비소세포 폐암으로 진단 받은 후 완전 절제술을 실시하고 수술 전후에 보조요법을 시행하지 않았던 환자 45예를 대상으로 CD31 단세포 항체(JC70항체)를 이용하여 면역조직화학 염색을 실시하여 종양 혈관신생 정도를 파악한 후 종양 혈관선생 정도와 병기, 림프절 전이, 전신전이 및 예후를 비교 하였다. 결 과 : 비소세포 폐암의 조직학적 유형에 관계없이 IIIA, IIIB 병기의 환자에서 I, II 병기의 환자에 비하여 종양 신생혈관의 수는 의미 있게 증가되어 있었다(p<0.05). 선암종에서 림프절 전이가 있는 환자에서 림프절 전이가 없는 환자에 비하여 의미 있는 증가가 있었다(p<0.05). 선암종에서 편평상피세포 암종에 비하여 종양 신생혈관의 수는 의미 있게 증가되어 있었으며(p<0.05), I, II 병기와 N0병기에서는 선암종에서 편평상피세포 암종에 비하여 증가하는 경향을 보였으나 통계적 의미는 없었으며(p>0.05), IIIA, IIIB병기와 N1~3병기에서는 선암종이 편평상피세포 암종에 비하여 의미 있는 증가를 보였다(p<0.05). 조기전이가 일어난 환자(12개월 이내에 전선전이가 발견된 환자)에서 조기전이가 일어나지 않은 환자에 비하여 종양 신생혈관의 수는 의미 있게 증가되어 있었으며(p<0.05), 전체 대상의 종양 신생혈관 수의 중앙값(100배 시야 당 44개)을 기준으로 종양 신생혈관의 수가 많은 환자(>44개/100배 시야)는 적은 환자($\leq$44개/100배 시야)에 비하여 전신 전이율이 높았다(비교 위험도 10.83). 전체 대상환지에서 종양 신생혈관의 수가 많은 환자(>44개/100배 시야)는 적은 환자($\leq$44개/100배 시야)에 비하여 의미 있게 낮은 생존율을 보였다(p<0.05). 결 론 : 비소세포 폐암에서 종양 혈관신생은 병기, 림프절 전이(선암종에 한정되어), 조직학적 유형 및 조기전이와 관련성이 있으며, 종양신생혈관의 수가 증가할 수록 전신전이율이 높고 불량한 예후를 보임을 알 수 있었다. 이 결과로 비소세포 폐암에서 완전절제술 후 예후를 예측하고 전신적 보조요법을 시행할 환자를 선별하는데 있어서 종양 혈관신생 정도를 파악하는 것이 도움이 될 수 있을 것으로 생각된다.

  • PDF

여성후두암의 임상적 특성 (Clinical Characteristics of Female Laryngeal Cancer)

  • 권순영;정광윤;최종욱
    • 대한두경부종양학회지
    • /
    • 제11권2호
    • /
    • pp.132-136
    • /
    • 1995
  • The laryngeal cancer is a cancer of secondary sex organ, such as malignant tumors of the mammary gland, endometrium, and prostate. The clinical characteristics of the female laryngeal cancers are considered somewhat to be different from that of male. As cancer of the larynx is principally a disease of men, many investigations have showed the characteristics of the male laryngeal cancers. For understanding the clinical characteristics of the female laryngeal cancers, we analyzed 21 cases of laryngeal cancer in women, diagnosed and treated in our institute during the last 10 years. The results were, 1) In female subjects, supraglottis was most common subsite of laryngeal cancer(85.7%). 2) On histopathologic grade, the moderately differentiated squamous cell carcinoma was the most common (80.9%). 3) The positive neck nodes were 19 %, considered to be lower than that of total laryngeal cancer. 4) The treatment results, the 2 year disease free rate and 5 year survival rate were 88.9%, 83.3%, respectively. These results suggest, therefore, female laryngeal cancers are more likely to be supraglottic cancer than glottic cancer. In spite of high incidence of supraglottic cancer, the nodal metastases are rare, the prognosis appeared to be good.

  • PDF